Senti Biosciences Company Top Insiders

SNTI Stock  USD 5.48  0.14  2.49%   
Senti Biosciences employs about 48 people. The company is managed by 11 executives with a total tenure of roughly 112 years, averaging almost 10.0 years of service per executive, having 4.36 employees per reported executive. Assessment of Senti Biosciences' management performance can provide insight into the firm performance.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Senti Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more detail on how to invest in Senti Stock please use our How to Invest in Senti Biosciences guide.

Senti Biosciences Management Team Effectiveness

The company has return on total asset (ROA) of (0.3302) % which means that it has lost $0.3302 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1107) %, meaning that it created substantial loss on money invested by shareholders. Senti Biosciences' management efficiency ratios could be used to measure how well Senti Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.82. The current Return On Capital Employed is estimated to decrease to -0.91. As of now, Senti Biosciences' Net Tangible Assets are increasing as compared to previous years. The Senti Biosciences' current Non Currrent Assets Other is estimated to increase to about 2.1 M, while Total Assets are projected to decrease to under 105.9 M.
The Senti Biosciences' current Common Stock Shares Outstanding is estimated to increase to about 4.7 M, while Net Loss is projected to decrease to (55 M).

Senti Biosciences Workforce Comparison

Senti Biosciences is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 685. Senti Biosciences holds roughly 48.0 in number of employees claiming about 7% of equities under Health Care industry.

Senti Biosciences Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Senti Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Senti Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Senti Biosciences insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2022-06-01
0.087
2
23
 362,519 
 27,166,834 
2014-06-01
7.0
14
2
 2,500,672 
 544,959 

Senti Biosciences Notable Stakeholders

A Senti Biosciences stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Senti Biosciences often face trade-offs trying to please all of them. Senti Biosciences' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Senti Biosciences' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Kanya MDHead PresidentProfile
Yvonne MBATreasurer CFOProfile
Susan BerlandSenior DirectorProfile
Dee DragonVice CultureProfile
Thomas ChungVice DevelopmentProfile
Susan KahlertControllerProfile
James CollinsChairperson CoFounderProfile
Wilson WongScientific BoardProfile
Deborah KnobelmanCFO TreasurerProfile
Philip LeeCoFounder CTOProfile
Mike RheeGeneral SecretaryProfile

About Senti Biosciences Management Performance

The success or failure of an entity such as Senti Biosciences often depends on how effective the management is. Senti Biosciences management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Senti management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Senti management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.78)(0.82)
Return On Capital Employed(0.87)(0.91)
Return On Assets(0.78)(0.82)
Return On Equity(1.39)(1.32)

Senti Biosciences Workforce Analysis

Traditionally, organizations such as Senti Biosciences use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Senti Biosciences within its industry.

Senti Biosciences Manpower Efficiency

Return on Senti Biosciences Manpower

Revenue Per Employee53.4K
Revenue Per Executive232.8K
Net Loss Per Employee1.5M
Net Loss Per Executive6.5M
Working Capital Per Employee1.2M
Working Capital Per Executive5.3M

Complementary Tools for Senti Stock analysis

When running Senti Biosciences' price analysis, check to measure Senti Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Senti Biosciences is operating at the current time. Most of Senti Biosciences' value examination focuses on studying past and present price action to predict the probability of Senti Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Senti Biosciences' price. Additionally, you may evaluate how the addition of Senti Biosciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA